Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial
Claus G RoehrbornVolume:
58
Year:
2001
Language:
english
DOI:
10.1016/s0090-4295(01)01448-0
File:
PDF, 125 KB
english, 2001